Home Alzheimer’s Disease Jeffrey S. Weber, MD, PhD, Discusses Anti-IL-6 Agents in Treating COVID-19-Induced Pneumonia

Jeffrey S. Weber, MD, PhD, Discusses Anti-IL-6 Agents in Treating COVID-19-Induced Pneumonia

Anti-IL-6 agents have been suggested to treat critically ill patients with coronavirus disease 2019 (COVID-19) pneumonia, sparking the development of randomized clinical trials to quickly evaluate the safety and efficacy of these agents in treating the virus. 

Jeffrey S. Weber, MD, PhD, deputy director at NYU Langone’s Perlmutter Cancer Center and co-director of the Melanoma Research Program, explained that these agents are being explored because a small portion of patients who are infected with COVID-19 have a cytokine storm syndrome. 

“It’s just this violent release of substances that normally are utilized by the immune system for good purposes, and they are so vigorously secreted by immune cells that they cause detrimental consequences to the body. It’s kind of what happens when you have sepsis, meaning you have a blood infection and the bacteria, for example, start to…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

All About Glioblastoma : braincancer

A splitting headache that continues non-stop. A weak spot in the muscular tissues and being unable to stroll a small distance. Feeling abnormally sleepy at random durations of the day.For many persons with glioblastoma...

please help us fundraise (501c3 non-profit) : braincancer

I work with OurBrainBank, a start-up non-profit dedicated to moving glioblastoma from terminal to treatable, powered by patients.We're a registered 501c3 non-profit in the...

Recent Comments